| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 10/02/2008 | WO2008116304A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists |
| 10/02/2008 | WO2008062167A3 Melatonin derivatives and their use as antioxidants |
| 10/02/2008 | WO2008028954A3 Novel compounds and compositions thereof |
| 10/02/2008 | US20080242873 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
| 10/02/2008 | US20080242872 Amorphous carvedilol phosphate and method of manufacturing thereof |
| 10/02/2008 | US20080242829 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
| 10/02/2008 | US20080242719 Reduce tumor necrosis factor; phosphodiesterase inhibitor; antiinflammatory agents; anticancer agents; antidepressants; skin diosrders |
| 10/02/2008 | US20080242702 Paclitaxel enhancer compound |
| 10/02/2008 | US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis |
| 10/02/2008 | US20080242671 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/02/2008 | US20080242655 Aza-indolyl compounds and methods of use |
| 10/02/2008 | US20080242652 Indole derivatives and their metal conjugates and uses thereof |
| 10/02/2008 | US20080241833 Using primer extension to determine sequence of single nucleotide polymorphism; gene expression analysis |
| 10/02/2008 | US20080241589 Organic electroluminescent device |
| 10/02/2008 | CA2681771A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 10/02/2008 | CA2681146A1 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists |
| 10/01/2008 | EP1975243A1 A method of isolating stem cells |
| 10/01/2008 | EP1975159A1 2,3,4,9-Tetrahydro-1H-carbazoles |
| 10/01/2008 | EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
| 10/01/2008 | EP1975153A2 Protease inhibitors |
| 10/01/2008 | EP1973918A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 10/01/2008 | EP1973877A2 Cannibinoid receptor modulators |
| 10/01/2008 | EP1973876A2 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 10/01/2008 | EP1515717B1 Calcium salts of indole derived statins |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 10/01/2008 | EP1251862B1 Ophthalmic compositions for treating ocular hypertension |
| 10/01/2008 | CN101277945A Indol-3-yl-carbonyl-piperidin and piperazin derivatives |
| 10/01/2008 | CN101277934A Metabotropic glutamate-receptor-potentiating isoindolones |
| 10/01/2008 | CN101277933A Substituted propylamine derivatives and methods of their use |
| 10/01/2008 | CN101276849A Photoelectric conversion device |
| 10/01/2008 | CN101274910A Preparation of tert-butyl (3R, 5R)-3,5-dihydroxy-7-N-phthaloylimino heptanonate |
| 10/01/2008 | CN100422185C Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 10/01/2008 | CN100422176C Carbazole-containing compound and organic electroluminescence display device using the compound |
| 10/01/2008 | CN100422170C Process for porducing quinolonecarboxylic acid derivative |
| 10/01/2008 | CN100422146C Synthesis method of indapamide |
| 09/30/2008 | US7429677 3'-methylene-bis(6-((4-methylphenyl)sulfonylamino)-benzoic acid) , or its N-oxide form, salt, stereoisomeric form, racemic mixture, prodrug or ester; block HIV from entering the human cell by interfering with various phases of attachment and fusion between HIV and the cell; Anti HIV agent; AIDS |
| 09/30/2008 | US7429661 Intermediates for linezolid and related compounds |
| 09/30/2008 | US7429612 Indoline compound and medicinal use thereof |
| 09/30/2008 | US7429610 diindole compounds as anticancer agents; potentiation; effective against estrogen-dependent, estrogen-independent, drug-resistant and/or metastasized cancers |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/25/2008 | WO2008115252A1 Process for purifying 2-phenyl-3, 3 -bis (4-hydroxyphenyl) phthalimidine ( pppbp) |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008114270A1 Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof |
| 09/25/2008 | WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes |
| 09/25/2008 | WO2008113747A1 Medicaments useful as potassium channel modulators |
| 09/25/2008 | WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof |
| 09/25/2008 | WO2008056378A3 Novel process for the preparation of naratriptan hydrochloride |
| 09/25/2008 | US20080234496 In liquid solution; decoloring; using activated carbon fibers; regeneration of carbon fibers using methanol at alkaline pH |
| 09/25/2008 | US20080234493 Ramipril; condensation of 1-ethoxycarbonyl-3-phenylpropylsalanine with racemic mixture |
| 09/25/2008 | US20080234492 Process for the Preparation of Carvedilol |
| 09/25/2008 | US20080234359 Reducing tumor necrosis factor, phosphodiesterase inhibitor; anticancer agents; leukemia; antidepressants; antiinflammatory agents; respiratory system disorders |
| 09/25/2008 | US20080234358 E-series of prostaglandin (EP) receptors; [[4-(4,9-dipropoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl) phenyl]acetic acid |
| 09/25/2008 | US20080234357 Central nervous system disorders; oxidation resistance; antitumor agents; Alzheimer's disease; 3-(2-hydroxyethyl)indole |
| 09/25/2008 | US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 09/25/2008 | US20080234290 New indole or benzimidazole derivatives as cb1 inverse agonists |
| 09/25/2008 | US20080234171 Diluting concentrated aqueous imidoalkanepercarboxylic acids (beta-crystal) with an aqueous solution having a pH of 2-5, preferably at 10-25 degrees C.; applying a shear force to the solution of at least 5000 s-1, until a constant dynamic viscosity is obtained; and dilution to less than 7% peracid |
| 09/25/2008 | US20080233102 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity |
| 09/25/2008 | CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 09/24/2008 | EP1972619A1 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative |
| 09/24/2008 | EP1971575A1 Anthraquinone derivatives as markers for liquids |
| 09/24/2008 | EP1971574A2 Bicyclic heterocyclic compounds as antiinflammatory or antiallergic agents |
| 09/24/2008 | EP1885725B1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 09/24/2008 | EP1387827B1 Synthesis of cyclopentadiene derivatives |
| 09/24/2008 | CN101273008A Spirofluorene derivative, material for light-emitting element, light-emitting element, light-emitting device, and electronic device |
| 09/24/2008 | CN101270075A Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative |
| 09/24/2008 | CN101270074A Method for preparing high purity mitiglinide calcium |
| 09/24/2008 | CN101270073A Biphenyl compound with dissymmetrical structure, preparation method and application thereof |
| 09/24/2008 | CN101270072A Right-handed indobufen and use for preparing medicament |
| 09/24/2008 | CN101270071A Method for synthesizing 1-alkyl-2-alkoxyl-3-indole aldoxime derivant |
| 09/24/2008 | CN101270069A Synthesis of taxol enhancers |
| 09/24/2008 | CN100420672C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 09/23/2008 | US7427682 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 09/23/2008 | US7427657 Aromatic sulfenates for type 1 phototherapy |
| 09/23/2008 | US7427638 Treatment may include administration of a second active agent, including but not limited to, an anti-inflammatory agent, an immnunosuppressant, mycophenolate mofetil, a biologic agent, or a Cox-2 inhibitor |
| 09/23/2008 | US7427632 Factor Xa inhibitors |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/18/2008 | WO2008111474A1 Process for production of indole compound |
| 09/18/2008 | WO2008110008A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | WO2008087278A3 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 09/18/2008 | WO2008082508A3 Process for the preparation of 6,6-dimethyl-3-azabicyclo- [3.1.0]- hexane compounds utilizing bisulfite intermediate |
| 09/18/2008 | WO2008048981A3 Indole antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 09/18/2008 | WO2008036967A3 Novel heterocyclic compounds as lasy activators |
| 09/18/2008 | US20080227981 Charge transport compositions and electronic devices made with such compositions |
| 09/18/2008 | US20080227976 Process for producing chirally enriched aspartic and glutamic acid derivatives by subjecting a diazoketone derivative to conditions that effect rearrangement to form the corresponding homologation product; useful for preparing compounds that are caspase inhibitors |
| 09/18/2008 | US20080227845 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 09/18/2008 | US20080227843 Therapeutic use of n-(1h-indolyl)-1h-indole-2-carboxamide derivatives |
| 09/18/2008 | US20080227823 (E)-4-(3-(3-bromo-4-fluorophenyl)acrylamido)-N-(2-(5-fluoro-1H-indol-3-yl)ethyl)piperidine-4-carboxamide; ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity |
| 09/18/2008 | US20080227820 cis-6-Fluoro-1-{[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}-1,2,3,4-tetrahydro-5-methoxy-4,4-dimethyl-6-(trifluoromethyl)naphthalene-2-ol; selectivity towards the glucocorticoid receptor (GR) is improved compared to the other steroid receptors |
| 09/18/2008 | US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma. |
| 09/18/2008 | US20080227794 Metabotropic Glutamate-Receptor-Potentiating Isoindolones |
| 09/18/2008 | US20080227684 Small Molecule Inhibitors of PDZ Interactions |
| 09/18/2008 | US20080226860 Cyanine dyes and use thereof |
| 09/18/2008 | DE102007012284A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments |
| 09/18/2008 | CA2681118A1 Amide derivatives as calcium channel blockers |
| 09/18/2008 | CA2677146A1 Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents |
| 09/17/2008 | EP1968939A2 Inhibitors of ccr9 activity |
| 09/17/2008 | EP1968938A1 Substituted propiolic acid amides and their use for producing drugs |